F. Lejeune

2.2k total citations
39 papers, 1.8k citations indexed

About

F. Lejeune is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, F. Lejeune has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in F. Lejeune's work include Neurotransmitter Receptor Influence on Behavior (16 papers), Receptor Mechanisms and Signaling (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). F. Lejeune is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (16 papers), Receptor Mechanisms and Signaling (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). F. Lejeune collaborates with scholars based in France, Belgium and Canada. F. Lejeune's co-authors include Alain P. Gobert, Jean‐Michel Rivet, Adrian Newman‐Tancredi, Mark J. Millan, Mark J. Millan, Didier Cussac, Jean‐Paul Nicolas, Valérie Pasteau, Valérie Audinot and Laetitia Cistarelli and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

F. Lejeune

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Lejeune France 16 1.1k 666 323 270 267 39 1.8k
A. Tagliamonte Italy 28 1.1k 1.0× 536 0.8× 161 0.5× 137 0.5× 207 0.8× 65 1.9k
Lynne E. Rueter United States 28 779 0.7× 780 1.2× 224 0.7× 130 0.5× 317 1.2× 51 1.8k
Shanaz M. Tejani‐Butt United States 29 1.3k 1.1× 637 1.0× 239 0.7× 167 0.6× 385 1.4× 52 2.1k
E. S. Vizi Hungary 21 1.6k 1.4× 1.3k 1.9× 325 1.0× 226 0.8× 237 0.9× 50 2.7k
Martine Daoust France 28 1.5k 1.3× 534 0.8× 456 1.4× 200 0.7× 225 0.8× 75 2.3k
G E Duncan United States 20 1.6k 1.4× 940 1.4× 180 0.6× 91 0.3× 348 1.3× 31 2.5k
Maria Rosaria Domenici Italy 29 1.4k 1.2× 712 1.1× 298 0.9× 97 0.4× 301 1.1× 78 2.3k
Tania O. Stean United Kingdom 21 1.4k 1.2× 1.1k 1.6× 247 0.8× 160 0.6× 302 1.1× 31 2.2k
Albert Sattin United States 22 1.0k 0.9× 792 1.2× 183 0.6× 180 0.7× 99 0.4× 61 2.0k
Kirsten Krebs-Thomson United States 10 1.2k 1.1× 674 1.0× 140 0.4× 78 0.3× 329 1.2× 10 1.8k

Countries citing papers authored by F. Lejeune

Since Specialization
Citations

This map shows the geographic impact of F. Lejeune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lejeune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lejeune more than expected).

Fields of papers citing papers by F. Lejeune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lejeune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lejeune. The network helps show where F. Lejeune may publish in the future.

Co-authorship network of co-authors of F. Lejeune

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lejeune. A scholar is included among the top collaborators of F. Lejeune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lejeune. F. Lejeune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefèvre, C., et al.. (2015). Verrucous carcinoma on a chronic sacral pressure ulcer in a patient with meningomyelocele. Case report and review of the literature. Annals of Physical and Rehabilitation Medicine. 58(2). 110–113.
2.
Millan, Mark J., Alain P. Gobert, Jean‐Michel Rivet, et al.. (2000). Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopram. European Journal of Neuroscience. 12(3). 1079–1095. 139 indexed citations
4.
Lejeune, F. & Mark J. Millan. (2000). Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5‐HT1Areceptors. European Journal of Neuroscience. 12(9). 3265–3275. 23 indexed citations
6.
Millan, Mark J., F. Lejeune, Alain P. Gobert, et al.. (2000). S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.. PubMed. 295(3). 1206–22. 79 indexed citations
8.
Andrieu, Jean‐Marie, Jean-Philippe Jaı̈s, P Colonna, et al.. (1998). Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin’s disease at advanced stages. Annals of Oncology. 9(2). 195–203. 16 indexed citations
9.
Lejeune, F., Adrian Newman‐Tancredi, Valérie Audinot, & Mark J. Millan. (1997). Interactions of (+)- and (−)-8- and 7-Hydroxy-2-(Di-n-Propylamino)tetralin at Human (h)D3, hD2 and h Serotonin1A Receptors and Their Modulation of the Activity of Serotoninergic and Dopaminergic Neurones in Rats. Journal of Pharmacology and Experimental Therapeutics. 280(3). 1241–1249. 89 indexed citations
10.
Gobert, Alain P., F. Lejeune, Jean‐Michel Rivet, Laetitia Cistarelli, & Mark J. Millan. (1996). Dopamine D3 (Auto)receptors Inhibit Dopamine Release in the Frontal Cortex of Freely Moving Rats In Vivo. Journal of Neurochemistry. 66(5). 2209–2212. 48 indexed citations
12.
Millan, M J, Jean‐Michel Rivet, Valérie Audinot, et al.. (1995). Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1418–1427. 9 indexed citations
13.
Lejeune, F., et al.. (1988). Etude electrophysiologique de la tianeptine, nouveau stimulant du recaptage de la serotonine possedant une activite antidepressive. Neurophysiologie Clinique. 18(4). 369–381. 9 indexed citations
14.
Lowy, M T, F. Lejeune, R Heimann, & G Achten. (1981). Fibrome desmoïde – Transformation en fibrosarcome. Dermatology. 163(1). 125–136. 7 indexed citations
15.
Lejeune, F., F Turpin, & P Lortholary. (1978). [Unusual giant inclusions in blast cells during acute transformation of chronic myeloid leukemia. Cytochemical and ultrastructural study (author's transl)].. PubMed. 26(1). 7–11. 1 indexed citations
16.
Lejeune, F., et al.. (1976). Inclusions tubulaires dans les lymphocytes d'une leucémie a tricholeucocytes. Pathologie Biologie. 24(4). 4 indexed citations
17.
Lejeune, F., et al.. (1976). [Tubular inclusions in the lymphocytes in a case of "hairy cells leukemia" (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(4). 287–92. 4 indexed citations
18.
Lejeune, F., et al.. (1974). Effets comparés du Piribédil et de trois de ses métabolites sur le système extrapyramidal du rat. Cellular and Molecular Life Sciences. 30(1). 70–71. 14 indexed citations
19.
Lejeune, F., et al.. (1973). La cellule de Niemann-Pick. Aspects en cytologie optique et ultrastructurale.. Pathologie Biologie. 21(5). 6 indexed citations
20.
Turpin, F, et al.. (1971). Un cas d'anémie hémolytique avec stomatocytose.. 11(4). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026